Tower Research Capital LLC (Trc) Bicycle Therapeutics PLC Transaction History
Tower Research Capital LLC (Trc)
- $4.07 Billion
- Q1 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 411 shares of BCYC stock, worth $8,047. This represents 0.0% of its overall portfolio holdings.
Number of Shares
411
Previous 2,328
82.35%
Holding current value
$8,047
Previous $42,000
76.19%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding BCYC
# of Institutions
99Shares Held
30.6MCall Options Held
85.5KPut Options Held
11.6K-
Baker Bros. Advisors LP New York, NY4.94MShares$96.8 Million1.56% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.49MShares$68.3 Million2.87% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.25MShares$63.6 Million3.03% of portfolio
-
Armistice Capital, LLC New York, NY1.67MShares$32.7 Million0.57% of portfolio
-
Tybourne Capital Management (Hk) LTD Hong Kong, K31.55MShares$30.3 Million8.61% of portfolio
About BICYCLE THERAPEUTICS plc
- Ticker BCYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,676,100
- Market Cap $581M
- Description
- Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...